Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Juvederm Prescribers for Wrinkle Removal

Articles with lock require a subscription to GLG News | Request a free trial
Sunil DhawanSeptember 10, 2007
FDA issues warning to Melanocorp
Analysis of: FDA Issues Warning Letter To Melanocorp, Inc. For Illegal Sale Of Melanotan II -Agency Warns Consumers About Using And Purchasing Unapproved Product | www.medicalnewstoday.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
 The FDA warning to Melanocorp regarding their product Melanotan was justified. These warnings are far too few and infrequent, and numerous companies make claims without studies or substantiation. The agency is overwhelmed with NDA's, and has difficulty handling the work that currently exists....
Sunil DhawanJuly 12, 2007
Vaniqa's effect on laser hair removal
Analysis of: Laser Hair Removal Enhanced With Eflornithine Cream | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
I do not believe that Vaniqa will have a negative effect on Laser hair removal as its efficacy is only temporary. In fact we use it as an adjunct for patients with resistant areas. Its use may actually enhance the use of Laser devices as they offer permanence. The products use may be increasing as more...
Sunil DhawanJune 18, 2007
Dermlex Launch
Analysis of: Advitech to finally launch Dermylex in US | www.nutraingredients-usa.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Advitech's launch of Dermylex will not have much of an impact on the psoriasis market. This is due to the fact that the product has minimal studies to back it up, and the company will rely on testimonials. This is not an effective way of marketing to physicians, and is difficult with patients....
Sunil DhawanJune 4, 2007
Melafind Phase three implications
Analysis of: Digital Diagnosis: New Tool for Detecting Skin Cancer | www.ehponline.org
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
If Melafinds phase three study results are positive then physicians will in general be receptive. The only issues are: 1. Ease of use/time to scan 2. Ability for non physician personnel to be trained to use the technology. 3. cost 4. Insurance reimbursement The technology may have more use at larger...
Sunil DhawanJune 4, 2007
Modus product-?efficacy
Analysis of: No Hydroquinone, Means No Worries for Modus. Dr.’s Applaud Europe’s New Import To Fight Signs of Aging | www.rushprnews.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
The new Modus product "without hydroquinone" cannot be fully evaluated on the basis of the currently available information. Decisions based on the opinions of a "Beauty Editor", and 6 years worth of studies with only 4 patients, are tenuous at best, and laughable at worst. It will be difficult to unseat...
May 29, 2007
New Organiceuticals May Help Bring Back Beauty!
Analysis of: http://www.nytimes.com/2007/04/26/fashion/26skin.html?_r=1&ref=health&oref=slogin | www.nytimes.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
All that glitters is not gold...but some might be! Anti-oxidants are the promise of saving our "hides"!
May 28, 2007
Couldn't agree more
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Keep Hydroquinones Around!
Sunil DhawanMay 24, 2007
FDA Hydroquinone ban may be premature
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
The possible ban of over the counter hydroquinone skin bleaching agents may be premature. We have used these agents for 20 years without any significant side effects including ochronosis or paradoxical darkening of the skin. These agents are only modestly effective at best. Most patients still...
May 17, 2007
Non-Invasive Screening of the Skin
Analysis of: New tool allows noninvasive screening of skin lesions | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
The company hopes to apply for European regulatory approval next year, with U.S. market approval and launch to follow. The current price of the device is 15,000 EUR. This device promises to be a remarkable time and money saver for medicine. Approximately 80-95% of lesions excised by dermatologists prove...
May 17, 2007
Pulsed Dye Vs Excimer Laser for Psoriasis
Analysis of: Psoriasis Challenge: pulsed dye vs. excimer lasers | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Patient satisfaction is high, but long term effects including possible carcinogenesis remain uncertain. Side effects included blistering, and hyperpigmentation in both groups, but no scarring.

Previous Page : 1 2 3 4 5 6 Next31 to 40 of 58

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747